MedTrace Logo

Vasculogenic Mimicry in Urothelial Carcinoma

NCT04295967 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-03-05

No results posted yet for this study

Summary

In this study, the investigators aim at:

1. Evaluate the presence of vasculogenic mimicry in urothelial carcinomas by CD31-PAS double staining.
2. Correlate the presence of vasculogenic mimicry with the clinicopathologic features as age, sex, TNM stage, pathological grade, recurrence, carcinoma in situ, lymphovascular emboli, lymph node metastasis, necrosis, surgical margin, multifocality and tumor size in urothelial carcinoma.

Conditions

Interventions

OTHER

formalin fixed paraffin embedded blocks

The study will be conducted using formalin fixed paraffin embedded blocks of seventy cases of urothelial carcinomas .CD31-PAS dual-staining will be performed to confirm the presence of VM.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abeer R Mohamed, professor · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-31
Primary Completion
2021-05-31
Completion
2022-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295967 on ClinicalTrials.gov